UK To Diverge On Biosimilar Data Requirements

But EU Off-Patent Industry Prefers Global Approach

 
• By Ian Schofield
  
GUIDANCE CONCEPT
The MHRA is to issue new guidance on biosimilars • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from United Kingdom

More from Europe